REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330909. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,737,889 | -61.3% | 238,700 | -14.7% | 0.00% | -50.0% |
| Q2 2023 | $7,081,738 | +6.3% | 279,800 | +35.3% | 0.00% | -33.3% |
| Q1 2023 | $6,661,028 | -47.5% | 206,800 | -69.9% | 0.00% | -50.0% |
| Q4 2022 | $12,694,942 | -33.1% | 687,700 | -2.2% | 0.01% | -25.0% |
| Q3 2022 | $18,981,000 | +1362.3% | 703,000 | +648.7% | 0.01% | +700.0% |
| Q2 2022 | $1,298,000 | – | 93,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 26,500 | $366,000 | 0.00% |
| JANE STREET GROUP, LLC | 93,900 | $1,298,000 | 0.00% |
| JPMORGAN CHASE & CO | 70,400 | $973,000 | 0.00% |
| SIMPLEX TRADING, LLC | 30,300 | $418,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |